Publication|Articles|July 8, 2024
Supplements and Featured Publications
- Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Advertisement
This clinical brief provides a background on DED and reviews DED treatment and challenges associated with prescription eye drops.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
T-DXd Delivers Strong Breast Cancer Outcomes Across Groups
2
Experts Warn Binge Drinking Drives Early-Onset Breast Cancer, While Cessation Reduces Risk
3
Clinicians Cite Progress Tracking as Top Barrier in Value-Based Care
4
Genome-Wide Analysis Uncovers Genetic Drivers of IPF and Its Overlap With COVID-19
5









































